Total Payments
$1,161
2024 Payments
$298.85
Companies
9
Transactions
62
Medicare Patients
1,130
Medicare Billing
$111,450
Payment Breakdown by Category
Food & Beverage$1,161 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,161 | 62 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $464.33 | 27 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $257.65 | 11 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $240.82 | 13 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $46.56 | 3 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $45.82 | 3 | $0 (2023) |
| Janssen Biotech, Inc. | $45.55 | 2 | $0 (2024) |
| QOL Medical, LLC | $26.82 | 1 | $0 (2023) |
| Ardelyx, Inc. | $18.12 | 1 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $15.69 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $298.85 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($121.17) |
| 2023 | $335.14 | 17 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($111.03) |
| 2022 | $465.03 | 27 | ABBVIE INC. ($421.56) |
| 2021 | $62.34 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($62.34) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/09/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/26/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Immunology | ||||||
| 06/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: Gastroenterology | ||||||
| 05/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Gastroenterology | ||||||
| 03/02/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 02/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Gastroenterology | ||||||
| 12/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Gastroenterology | ||||||
| 09/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Gastroenterology | ||||||
| 09/13/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/25/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/31/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/21/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $26.82 | General |
| Category: THERAPY FOR CSID | ||||||
| 05/31/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 261 | 261 | $131,670 | $24,889 |
| 2022 | 4 | 308 | 308 | $150,610 | $29,799 |
| 2021 | 4 | 334 | 335 | $149,340 | $33,750 |
| 2020 | 4 | 227 | 227 | $100,400 | $23,012 |
Total Patients
1,130
Total Services
1,131
Medicare Billing
$111,450
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 139 | 139 | $71,280 | $13,445 | 18.9% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 54 | 54 | $20,970 | $4,728 | 22.5% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 37 | 37 | $19,890 | $3,415 | 17.2% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 31 | 31 | $19,530 | $3,301 | 16.9% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 156 | 156 | $76,690 | $14,646 | 19.1% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 73 | 73 | $28,490 | $6,860 | 24.1% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 44 | 44 | $23,370 | $4,162 | 17.8% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 35 | 35 | $22,060 | $4,132 | 18.7% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 163 | 163 | $73,500 | $16,135 | 22.0% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 84 | 84 | $29,840 | $8,010 | 26.8% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 49 | 50 | $24,160 | $5,027 | 20.8% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 38 | 38 | $21,840 | $4,578 | 21.0% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 116 | 116 | $52,000 | $11,444 | 22.0% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2020 | 56 | 56 | $19,680 | $5,513 | 28.0% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 31 | 31 | $14,800 | $3,252 | 22.0% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2020 | 24 | 24 | $13,920 | $2,803 | 20.1% |
About David Kline, CRNA
David Kline, CRNA is a Nurse Anesthetist, Certified Registered healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760446132.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Kline, CRNA has received a total of $1,161 in payments from pharmaceutical and medical device companies, with $298.85 received in 2024. These payments were reported across 62 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,161).
As a Medicare-enrolled provider, Kline has provided services to 1,130 Medicare beneficiaries, totaling 1,131 services with total Medicare billing of $111,450. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Anesthetist, Certified Registered
- Other Specialties Certified Registered
- Location Lancaster, PA
- Active Since 04/13/2006
- Last Updated 10/01/2009
- Taxonomy Code 367500000X
- Entity Type Individual
- NPI Number 1760446132
Products in Payments
- ENTYVIO (Biological) $257.65
- XIFAXAN (Drug) $240.82
- RINVOQ (Biological) $128.47
- CREON (Drug) $110.79
- ZENPEP (Drug) $92.38
- MAVYRET (Drug) $88.10
- SKYRIZI (Biological) $79.41
- HUMIRA (Biological) $44.92
- Sucraid (Drug) $26.82
- TREMFYA (Drug) $25.06
- STELARA (Biological) $20.49
- IBSRELA (Drug) $18.12
- OCALIVA (Drug) $15.69
- LINZESS (Drug) $12.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Anesthetist, Certified Registered Doctors in Lancaster
Noel Boas, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $1,520
Nurse Anesthetist, Certified Registered $1,520
Heather Saunders, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $1,351
Nurse Anesthetist, Certified Registered $1,351
Mehrdad Vaziri, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $494.00
Nurse Anesthetist, Certified Registered $494.00
John Swircek, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $465.20
Nurse Anesthetist, Certified Registered $465.20
Ms. Betsy Geary, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $432.72
Nurse Anesthetist, Certified Registered $432.72
Peter Eaton, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $405.22
Nurse Anesthetist, Certified Registered $405.22